Ecuador

Ecuador: Exchange deadline extended after legal action

  • The government agreed last night to extend the deadline for its consent solicitation by one day to Monday 3 August

  • This follows legal action by some bondholders who are concerned about the treatment of non-tendering holders

  • Ecuador's approach could set a precedent for future sovereign debt restructurings

https://cdn.tellimer.com/providers/tellimer-avatarpng.png
Stuart Culverhouse @ Tellimer Research
July 31st, 2020
Subscribe to read this report

You can read this report by subscribing to a Starter or Pro plan today.

Already have an account? Log in

Subscribe to read this report

You can read this report by subscribing to a Starter or Pro plan today.

Already have an account? Log in

Most Read

1 ∙ Strategy Note ∙ Global
Fixed income strategy: 2023 in review – annus slightly less horribilis
2 ∙ Weekend Reading ∙ Global
The best and worst performing EM stocks so far this year
3 ∙ Strategy Note ∙ Global
Fixed income strategy: 2024 outlook – pick your battles
4 ∙ Strategy Note ∙ Global
6 lessons from EM Equities in 2023
5 ∙ Macro ∙ Pakistan
Pakistan IMF review sparks rally amid improved external trade and inflation

Disclosures

This report is independent investment research as contemplated by COBS 12.2 of the FCA Handbook and is a research recommendation under COBS 12.4 of the FCA Handbook. Where it is not technically a research recommendation because the subject of the research is not listed on any European exchange, it has nevertheless been treated as a research recommendation to ensure consistent treatment of all Tellimer's research. This report has been produced by the analyst(s) named above (the "Analyst").

The Analyst certifies that the views and forecasts expressed in this report accurately reflect their personal views about the subject, securities, or issuers specified herein. In addition, the Analyst certifies that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this report.

Research ratings explanation and full Tellimer disclaimers

This research is produced by a third party. The Tellimer team has had no editorial input into the content of the note.